Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study. Wang QX, Xiao BY, Cheng Y, Wu AW, et al. Eur J Cancer 2022;174:176-184.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang QX, Xiao BY, Cheng Y, Wu AW, et al. Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study. Eur J Cancer 2022;174:176-184.
PMID: 36030556